Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Dr. Joseph Williams is a highly accomplished molecular biologist and genetic researcher with over a decade of experience specializing in gene editing technologies and their application in hereditary diseases. Currently based in the biotech hub of Cambridge, Massachusetts, he is deeply involved in pioneering research that aims to unravel complex genetic mechanisms and develop innovative therapeutic interventions. His work often involves cutting-edge techniques such as CRISPR-Cas9, next-generation sequencing (NGS), and advanced bioinformatics analysis. Joseph is known for his meticulous approach to experimental design, his ability to translate complex scientific concepts into understandable terms, and his passion for mentoring junior scientists. He is committed to advancing the field of genetic medicine to improve patient outcomes and contribute to a deeper understanding of human biology.
Joseph Williams 🧬's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Led a team that successfully developed and patented a more efficient and targeted viral vector for delivering CRISPR-Cas9 components into somatic cells, significantly improving gene editing efficacy in pre-clinical models of genetic liver disorders.
Authored a seminal paper in 'Nature Genetics' detailing the discovery of novel non-coding RNA regulators involved in the progression of a rare neurodevelopmental syndrome, opening new avenues for therapeutic research.
Awarded by the International Society for Genomic Medicine in recognition of his significant contributions to understanding and manipulating genetic pathways for therapeutic benefit early in his independent career.
Successfully obtained a highly competitive R01 grant from the National Institutes of Health to fund a five-year research project investigating the role of epigenetic modifications in modulating gene expression in response to gene therapy.
Drop out
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Tech Nation was a prominent UK network that supported ambitious tech entrepreneurs and leaders through growth programs, visa schemes for tech talent, digital skills development, and by providing data-driven insights and research on the UK tech ecosystem. It aimed to fuel the growth of pioneering tech companies and build a strong national network to support the digital economy. Tech Nation ceased operations on March 31, 2023, after its core government funding was withdrawn and awarded to Barclays Eagle Labs.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.